Lidocaine Ameliorates Psoriasis by Obstructing Pathogenic CGRP SignalingMediated Sensory NeuronDendritic Cell Communication ScienceDirect Many treatment guidelines for psoriasis rely heavily on body surface area (BSA) involvement to determine disease severity and eligibility for systemic therapies like biologics. Traditionally, patients with less than 10% BSA involvementespecially What Science ACTUALLY Says About BPC 157 Benefits YouTube Frontiers Gut microbiota and psoriasis: pathogenesis, targeted therapy, and future directions